News Release

The results of a "weather-related pain survey" conducted with 16,000 people nationwide have been released. Weather-related pain occurs an average of two times a week, and one in five people experience it that interferes with their daily lives.

Differences between men and women in age-related changes in lips discovered

Rohto Digi-Eye® Contact Lenses, containing zinc sulfate hydrate to relieve eye strain caused by blue light, are now on sale.

We will release "My CONSTELLA" and "OVNI," digital tools that integrate real-world and online services for users and hair salons, on July 1st.

ROHTO V5 Tablets ActVision, an eye supplement that supports the maintenance of vision, is now on sale.

Detailed analysis of consumer and purchasing behavior trends by combining "weather data" and "healthcare-related data."

SKIO, a D2C brand targeting millennial women who demand both effectiveness and efficiency, is now available.

Rohto Pharmaceutical and Kaneka have agreed to a business partnership in the lacrimal duct catheter business.

Japan plans to conduct a first-of-its-kind corporate clinical trial of Regenerative medicine using allogeneic mesenchymal stem cells for severe COVID-19 pneumonia

Discovery of a component that increases exosome secretion from stem cells